pharmaphorum

JANUARY 18, 2022

Microsoft and CVS Health have announced a new strategic alliance focusing on personalised care and accelerating digital transformation for the benefit of CVS customers and its employees. David Rhew, MD, global chief medical officer and VP of healthcare at Microsoft, tells us, “Using Microsoft technology, CVS Health will develop a more agile, digital-first technology foundation.” Digital innovation and implementation have skyrocketed within healthcare due to the need to adapt quickly

Prescription Filling 118

Prescription Filling Insurance 118

Fierce Healthcare

JANUARY 18, 2022

Microsoft, Cleveland Clinic and Providence join coalition to innovate AI in healthcare. rtorrence. Tue, 01/18/2022 - 11:32.

137

137

Outsourcing Pharma

JANUARY 18, 2022

Regulatory bodies in the European Union have launched an initiative to develop the region as a focal point for clinical research and to better integrate clinical research in the European health system.

102

102

Fierce Healthcare

JANUARY 18, 2022

Study: Insurers spend nearly $130M a year on ivermectin prescriptions. pminemyer. Tue, 01/18/2022 - 16:23.

Insurance 145

Insurance 145

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

pharmaphorum

JANUARY 18, 2022

Targeted agents and immunotherapies are two of the most promising areas for significant advancements in cancer treatment. Envision Pharma’s scientific solutions division lead Rebecca Goldstein, discusses this topic and other developments that cancer patients and their loved ones should be paying attention to. People with cancer and their caregivers have long been active participants in discussions of how they are treated, but in the current digital information age, it is becoming more common for

96

96

Fierce Healthcare

JANUARY 18, 2022

CMS sets COVID-19 vaccination deadlines for healthcare workers in 24 more states. dmuoio. Tue, 01/18/2022 - 11:32.

Vaccines 119

Vaccines 119

Fierce Healthcare

JANUARY 18, 2022

Walgreens rolls out new COVID-19 data tracker to trace the spread of omicron, emerging variants. hlandi. Tue, 01/18/2022 - 17:38.

111

111

Outsourcing Pharma

JANUARY 18, 2022

The pharmaceutical company reports studies have demonstrated the main protease inhibitor of Paxlovid maintains in vitro efficiency against the variant.

Pharmaceutical Companies 97

Pharmaceutical Companies Pharmaceutical Companies 97

Fierce Healthcare

JANUARY 18, 2022

VA inks $13M deal with Google Cloud to accelerate app development for veterans. hlandi. Tue, 01/18/2022 - 10:22.

116

116

Outsourcing Pharma

JANUARY 18, 2022

The Medicines and Healthcare Products Regulatory Agency has released proposals to bolster trials legislation, asking citizens for input on the suggestions.

93

93

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

FDA

Fierce Healthcare

JANUARY 18, 2022

Lawmakers ratchet up pressure on CMS to change Part B premiums after Aduhelm price drop. rking. Tue, 01/18/2022 - 14:05.

105

105

pharmaphorum

JANUARY 18, 2022

Cancer Research UK’s Centre for Drug Development, working with the Ludwig Institute for Cancer Research and Vaccitech, has begun a phase I/IIa clinical trial of a new lung cancer vaccine. The novel immunotherapeutic, VTP-600, is not a preventative vaccine — it’s intended for patients who have recently been diagnosed with non-small cell lung cancer. The initial trial will enrol 86 patients, across 10 specialist hospitals in the UK, testing for safety and efficacy in patients who are also receivin

Immunization 64

Immunization Vaccines Hospitals 64

Fierce Healthcare

JANUARY 18, 2022

Fierce JPM Week: Verily's Lee details 'strong' revenue growth as company eyes employer market in 2022. hlandi. Tue, 01/18/2022 - 15:37.

98

98

pharmaphorum

JANUARY 18, 2022

Poolbeg Pharma has licenced a candidate for nasal immunotherapy, developed by the University of Warwick, targeting respiratory infections, such as influenza and coronavirus. The RNA-based immunotherapy drug was developed at the University of Warwick and drew on 20 years of research, led by prominent virologists Professor Andrew Easton and Professor Nigel Dimmock.

Vaccines 59

Vaccines 59

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management Software

Fierce Healthcare

JANUARY 18, 2022

As TEFCA goes live, HHS hits major interoperability milestone. hlandi. Tue, 01/18/2022 - 11:51.

115

115

pharmaphorum

JANUARY 18, 2022

Scotland has approved AstraZeneca’s Tagrisso (osimertinib) as a monotherapy for the for the first-line treatment of adult patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) with activating epidermal growth factor receptor (EGFR) mutations. Lung cancer is linked to a quarter of all cancer deaths in the country, with almost half of lung cancers in Scotland diagnosed at a late stage.

59

59

Fierce Healthcare

JANUARY 18, 2022

Low-value care most common among systems with fewer primary care physicians, investor ownership. dmuoio. Tue, 01/18/2022 - 15:54.

98

98

pharmaphorum

JANUARY 18, 2022

Two Spanish pharma companies are joining forces to identify new oral treatments for immune-inflammatory skin diseases with high unmet medical needs. Almirall and IRB Barcelona (the Institute for Research in Biomedicine), will conduct research using molecular glue degraders, a new approach to the skin diseases under scrutiny. The use of monovalent degraders, which enable the targeted degradation of disease-relevant proteins, offers a new avenue to reach tissue that cannot be targeted with convent

Immunization 52

Immunization 52

Fierce Healthcare

JANUARY 18, 2022

LetsGetChecked launches antigen COVID testing, virtual observation service for employers. agliadkovskaya. Tue, 01/18/2022 - 15:49.

96

96

Pharma Mirror

JANUARY 18, 2022

ADELAIDE, Avance Clinical, the largest premium Australian Contract Research Organisation (CRO) for international biotechs, has secured a significant investment from global private equity firm, The Riverside Company (Riverside), to support further regional and global expansion. The investment values the company in excess of $200m. Avance Clinical is taking meetings with biotechs to discuss the benefits of conducting trials in Australia, including no IND requirement and an attractive 43.5% rebate,

52

52

Fierce Healthcare

JANUARY 18, 2022

COVID-19 pandemic taking a toll on doctors outside of work, survey finds. hlandi. Tue, 01/18/2022 - 12:42.

105

105

Pharma Mirror

JANUARY 18, 2022

BARCELONA, Spain, a global biopharmaceutical company focused on skin health, and IRB Barcelona (the Institute for Research in Biomedicine), an independent, international research centre engaged in fundamental and applied biomedical science, announced today a research collaboration to identify new oral treatments for immune-inflammatory skin diseases with remaining high unmet medical needs using molecular glue degraders, a novel therapeutic modality.

Immunization 52

Immunization 52

pharmaphorum

JANUARY 18, 2022

SMi’s 9th Annual Conference. Pre-Filled Syringes East Coast. Main Conference: April 25 – 26, 2022 | Workshops: April 27, 2022. Sheraton Boston Hotel, Boston, MA, USA. www.pfsamericas.com/pharmaphorum. Sponsors are: SCHOTT, ZEON, Owen Mumford Pharmaceutical Services, PHC Corporation, POLYPLASTICS- TOPAS, Weiss-Aug Group, Baumann Medical, BD Medical, West Pharmaceutical Services.

Packaging 52

Packaging FDA Documentation Vaccines 52

Fierce Healthcare

JANUARY 18, 2022

Bristol Myers Squibb becomes 12th drugmaker to announce 340B contract pharmacy restrictions. rking. Tue, 01/18/2022 - 16:40.

52

52

pharmaphorum

JANUARY 18, 2022

SMi’s 5th Annual 3D Cell Culture Conference. Virtual Conference: Online Access Only. 9-10 February 2022. [link]. Sponsored by: CELLINK, CelVivo, Promega and Newcells Biotech. Developing Complex, Translatable and Physiologically-Relevant Cellular Models in vitro. Conference Co-Chairs: Stefan Przyborski, Professor of Cell Technology, Durham University and Philip Hewitt, Global Head of Early Investigative Toxicology, Merck. 3D Cell Culture is gaining momentum in the pharmaceutical industry on accou

52

52

Fierce Healthcare

JANUARY 18, 2022

Humana taps exec to lead its home health business. pminemyer. Tue, 01/18/2022 - 12:30.

52

52

Pharma Times

JANUARY 18, 2022

Cancer Research UK announces clinical trial for most common type of lung cancer

Vaccines 54

Vaccines 54

Pharma Times

JANUARY 18, 2022

The NHS launches world-first study investigating genetic testing for common diseases

46

46